[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627234":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":19,"locations":25,"responsibleParty":43,"collaborators":18,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":18,"eligibilityCriteria":52,"healthyVolunteers":49,"sex":53,"minAge":54,"maxAge":18,"enrollmentInfo":55,"targetDuration":18,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":18,"overallStatus":28,"whyStopped":18,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Azienda Ospedaliero-Universitaria di Parma","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Hematological malignancies","Patients with hematological malignancies either treatment free or relapsed\u002F refractory",[12],"Other: Genetic, molecular and\u002For omics analyses",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":18},"Genetic, molecular and\u002For omics analyses","The focus of our scientific approach is based on genetic, molecular and\u002For omics analyses performed with new technologies (Nanostring, NGS, single cell technologies, radiomics)",[9],null,[20],{"name":21,"role":22,"phone":23,"phoneExt":18,"email":24},"Giovanni Roti, Associate Professor","CONTACT","+39 0521 702200","giovanni.roti@unipr.it",[26],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"University of Parma","RECRUITING","Parma","PR","43126","Italy","IT",{"type":35,"coordinates":36},"Point",[37,38],10.32618,44.79935,{"lat":38,"lon":37},[41],{"name":42,"role":22,"phone":18,"phoneExt":18,"email":24},"Giovanni Roti, Medical doctor, PhD",{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":27,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Giovanni Roti","Full Professor","100627234","chemogenomic-profiling-in-hematological-malignancies-hem-profiling-2021-100627234",false,"NCT07445984","Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)","Inclusion Criteria:\n\n* Patient aged \\>1 year old, referred for evaluation to the University Hospital of Parma;\n* Retrospective study: previously patients with hematological malignancies;\n* Prospective study: 1) patients with clinical suspect of hematological malignancies which requires a diagnostic assessment using peripheral blood drawn, bone marrow aspirate\u002Fbiopsy, lymph nodes biopsies or biopsies of tissues with metastatic involvement including liquor from rachicentesis, tissue aspirate etc. 2) patients with clinical suspect of relapsed\u002Frefractory onco-hematological disorder, which requires a diagnostic assessment using bone marrow aspirate\u002Fbiopsy or biopsies of tissues with metastatic involvement including lymph nodes, liquor from rachicentesis, tissue aspirate etc. 3) patients that progress in blastic transformation from a chronic condition or suspect of relapsed\u002Frefractory hematological disease, which requires a diagnostic assessment using peripheral blood drawn, bone marrow aspirate\u002Fbiopsy, lymph nodes biopsies or biopsies of tissues with metastatic involvement including liquor from rachicentesis, tissue aspirate etc;\n* Written informed consent. Retrospective study: informed consent will be signed during the first follow-up visit.\n\nExclusion Criteria:\n\n* Age \\\u003C1 year old\n* Patients who are unable to provide informed consent prior to any procedure for any reason.","ALL","1 Year",{"count":56,"type":57},250,"ESTIMATED","INTERVENTIONAL",[60],"NA","The study will be conducted retrospectively and prospectively, using bone marrow (BM) or peripheral blood (PB) samples or biopsies of lymph nodes or tissues with metastatic involvement taken from previously stored samples here at the University Hospital of Parma or taken from patients that need to underwent diagnostic evaluation for a suspect or a defined diagnosis of hematological malignancies collected at the University Hospital of Parma.",[63,64,65,66,67],"Chronic Leukemia","Acute Leukemia","Myeloproliferative Disorders","Lymphoproliferative Disorders","Myelodysplastic Disorders","2026-02-25",{"date":70,"type":71},"2026-03-03","ACTUAL",{"date":73,"type":71},"2021-07-28",{"date":75,"type":57},"2026-07-28",{"name":5,"class":6},1]